These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 23877361)

  • 1. Management of recurrent medulloblastoma in adult patients: a systematic review and recommendations.
    Kostaras X; Easaw JC
    J Neurooncol; 2013 Oct; 115(1):1-8. PubMed ID: 23877361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of high-dose chemotherapy and autologous stem cell transplantation in patients with relapsed medulloblastoma: a report on the Korean Society for Pediatric Neuro-Oncology (KSPNO)-S-053 study.
    Park JE; Kang J; Yoo KH; Sung KW; Koo HH; Lim DH; Shin HJ; Kang HJ; Park KD; Shin HY; Kim IH; Cho BK; Im HJ; Seo JJ; Park HJ; Park BK; Ahn HS
    J Korean Med Sci; 2010 Aug; 25(8):1160-6. PubMed ID: 20676326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose chemotherapy with autologous stem cell rescue for children with high risk and recurrent medulloblastoma and supratentorial primitive neuroectodermal tumors.
    Pérez-Martínez A; Lassaletta A; González-Vicent M; Sevilla J; Díaz MA; Madero L
    J Neurooncol; 2005 Jan; 71(1):33-8. PubMed ID: 15719272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment results of adults and children with medulloblastoma NCI, Cairo University experience.
    Khalil EM
    J Egypt Natl Canc Inst; 2008 Jun; 20(2):175-86. PubMed ID: 20029474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Will high dose chemotherapy followed by autologous bone marrow transplantation supplant cranio-spinal irradiation in young children treated for medulloblastoma?
    Dupuis-Girod S; Hartmann O; Benhamou E; Doz F; Mechinaud F; Bouffet E; Coze C; Kalifa C
    J Neurooncol; 1996 Jan; 27(1):87-98. PubMed ID: 8699230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced-dose craniospinal radiotherapy followed by tandem high-dose chemotherapy and autologous stem cell transplantation in patients with high-risk medulloblastoma.
    Sung KW; Lim DH; Son MH; Lee SH; Yoo KH; Koo HH; Kim JH; Suh YL; Joung YS; Shin HJ
    Neuro Oncol; 2013 Mar; 15(3):352-9. PubMed ID: 23258845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salvage therapy for progressive, treatment-refractory or recurrent pediatric medulloblastoma: a systematic review protocol.
    Adile AA; Kameda-Smith MM; Bakhshinyan D; Banfield L; Salim SK; Farrokhyar F; Fleming AJ
    Syst Rev; 2020 Mar; 9(1):47. PubMed ID: 32127049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome and prognostic factors of desmoplastic medulloblastoma treated within a multidisciplinary treatment concept.
    Rieken S; Gaiser T; Mohr A; Welzel T; Witt O; Kulozik AE; Wick W; Debus J; Combs SE
    BMC Cancer; 2010 Aug; 10():450. PubMed ID: 20731859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proposed strategy for the use of high-dose chemotherapy with stem cell rescue and intrathecal topotecan without whole-brain irradiation for infantile classic medulloblastoma.
    Yamada A; Moritake H; Kamimura S; Yamashita S; Takeshima H; Nunoi H
    Pediatr Blood Cancer; 2014 Dec; 61(12):2316-8. PubMed ID: 25174961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose chemotherapy with autologous stem cell rescue followed by posterior fossa irradiation for local medulloblastoma recurrence or progression after conventional chemotherapy.
    Ridola V; Grill J; Doz F; Gentet JC; Frappaz D; Raquin MA; Habrand JL; Sainte-Rose C; Valteau-Couanet D; Kalifa C
    Cancer; 2007 Jul; 110(1):156-63. PubMed ID: 17541945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EANO-EURACAN clinical practice guideline for diagnosis, treatment, and follow-up of post-pubertal and adult patients with medulloblastoma.
    Franceschi E; Hofer S; Brandes AA; Frappaz D; Kortmann RD; Bromberg J; Dangouloff-Ros V; Boddaert N; Hattingen E; Wiestler B; Clifford SC; Figarella-Branger D; Giangaspero F; Haberler C; Pietsch T; Pajtler KW; Pfister SM; Guzman R; Stummer W; Combs SE; Seidel C; Beier D; McCabe MG; Grotzer M; Laigle-Donadey F; Stücklin ASG; Idbaih A; Preusser M; van den Bent M; Weller M; Hau P
    Lancet Oncol; 2019 Dec; 20(12):e715-e728. PubMed ID: 31797797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time, pattern, and outcome of medulloblastoma relapse and their association with tumour biology at diagnosis and therapy: a multicentre cohort study.
    Hill RM; Richardson S; Schwalbe EC; Hicks D; Lindsey JC; Crosier S; Rafiee G; Grabovska Y; Wharton SB; Jacques TS; Michalski A; Joshi A; Pizer B; Williamson D; Bailey S; Clifford SC
    Lancet Child Adolesc Health; 2020 Dec; 4(12):865-874. PubMed ID: 33222802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose carboplatin, thiotepa, and etoposide with autologous stem cell rescue for patients with previously irradiated recurrent medulloblastoma.
    Dunkel IJ; Gardner SL; Garvin JH; Goldman S; Shi W; Finlay JL
    Neuro Oncol; 2010 Mar; 12(3):297-303. PubMed ID: 20167818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose chemotherapy and autologous stem cell rescue in children with newly diagnosed high-risk or relapsed medulloblastoma or supratentorial primitive neuroectodermal tumor.
    Sung KW; Yoo KH; Cho EJ; Koo HH; Lim DH; Shin HJ; Ahn SD; Ra YS; Choi ES; Ghim TT
    Pediatr Blood Cancer; 2007 Apr; 48(4):408-15. PubMed ID: 17066462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Updates on Management of Adult Medulloblastoma.
    Majd N; Penas-Prado M
    Curr Treat Options Oncol; 2019 Jun; 20(8):64. PubMed ID: 31236711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of high-dose chemotherapy for recurrent medulloblastoma and other CNS primitive neuroectodermal tumors.
    Gajjar A; Pizer B
    Pediatr Blood Cancer; 2010 Apr; 54(4):649-51. PubMed ID: 20146223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relapse patterns in pediatric embryonal central nervous system tumors.
    Perreault S; Lober RM; Carret AS; Zhang G; Hershon L; Décarie JC; Yeom K; Vogel H; Fisher PG; Partap S
    J Neurooncol; 2013 Nov; 115(2):209-15. PubMed ID: 23921420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multivariate analysis of prognostic factors in adult patients with medulloblastoma. Retrospective study of 156 patients.
    Carrie C; Lasset C; Alapetite C; Haie-Meder C; Hoffstetter S; Demaille MC; Kerr C; Wagner JP; Lagrange JL; Maire JP
    Cancer; 1994 Oct; 74(8):2352-60. PubMed ID: 7922986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics and outcomes of medulloblastoma in adults.
    Ang C; Hauerstock D; Guiot MC; Kasymjanova G; Roberge D; Kavan P; Muanza T
    Pediatr Blood Cancer; 2008 Nov; 51(5):603-7. PubMed ID: 18649371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New perspectives in the treatment of adult medulloblastoma in the era of molecular oncology.
    Brandes AA; Bartolotti M; Marucci G; Ghimenton C; Agati R; Fioravanti A; Mascarin M; Volpin L; Ammannati F; Masotto B; Gardiman MP; De Biase D; Tallini G; Crisi G; Bartolini S; Franceschi E
    Crit Rev Oncol Hematol; 2015 Jun; 94(3):348-59. PubMed ID: 25600839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.